Low-dose growth hormone and human immunodeficiency virus-associated lipodystrophy syndrome: a pilot study.
about
Lipodystrophy: pathophysiology and advances in treatmentRecombinant human growth hormone therapy in HIV-associated wasting and visceral adiposity.Toxic metabolic syndrome associated with HAART.Low-dose growth hormone therapy reduces inflammation in HIV-infected patients: a randomized placebo-controlled study.
P2860
Low-dose growth hormone and human immunodeficiency virus-associated lipodystrophy syndrome: a pilot study.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Low-dose growth hormone and hu ...... rophy syndrome: a pilot study.
@en
Low-dose growth hormone and hu ...... rophy syndrome: a pilot study.
@nl
type
label
Low-dose growth hormone and hu ...... rophy syndrome: a pilot study.
@en
Low-dose growth hormone and hu ...... rophy syndrome: a pilot study.
@nl
prefLabel
Low-dose growth hormone and hu ...... rophy syndrome: a pilot study.
@en
Low-dose growth hormone and hu ...... rophy syndrome: a pilot study.
@nl
P2093
P2860
P50
P1476
Low-dose growth hormone and hu ...... rophy syndrome: a pilot study.
@en
P2093
Andersen UB
Haugaard SB
Nielsen JO
P2860
P304
P356
10.1111/J.1365-2362.2004.01380.X
P577
2004-08-01T00:00:00Z